↓ Skip to main content

Cochrane Database of Systematic Reviews

Urinary alkalisation for symptomatic uncomplicated urinary tract infection in women

Overview of attention for article published in Cochrane database of systematic reviews, April 2016
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
7 tweeters
facebook
2 Facebook pages

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
84 Mendeley
Title
Urinary alkalisation for symptomatic uncomplicated urinary tract infection in women
Published in
Cochrane database of systematic reviews, April 2016
DOI 10.1002/14651858.cd010745.pub2
Pubmed ID
Authors

Dermot B O'Kane, Sameer K Dave, Neel Gore, Farhaan Patel, Tammy C Hoffmann, Jeanne L Trill, Chris B Del Mar

Abstract

Uncomplicated urinary tract infection (UTI) is the most common bacterial infection in women, characterised by dysuria and urinary frequency. Urinary alkalisers are widely used in some countries for the symptomatic treatment of uncomplicated UTI, and they are recommended in some national formularies. However, there is a lack of empirical evidence to support their use for UTI and some healthcare guidelines advise against their use. We aimed to look at the benefits and harms of the use of urinary alkalisers for the treatment of uncomplicated UTIs in adult women. We searched the Cochrane Kidney and Transplant Specialised Register to 19 January 2016 through contact with the Trials Search Co-ordinator using search terms relevant to this review. All randomised controlled trials (RCTs) and quasi-RCTs on the use of (any) urinary alkalisers (either exclusively or non-exclusively) for the symptomatic treatment of uncomplicated UTI amongst women aged 16 and over, were included. Studies were eligible if they included patients whose diagnosis of UTI was decided by symptoms alone, or positive urine dipstick test or urine culture; and patients with recurrent UTI, provided patients had no symptoms of UTI in the two weeks prior to the onset of symptoms that lead them to seek medical advice. Studies were ineligible if they studied patients with complicated UTIs; immune-compromising conditions; acute pyelonephritis; or chronic conditions such as interstitial cystitis. Three authors independently assessed and screened papers, and this was repeated by two separate authors (independently). An additional investigator acted as arbitrator, where necessary. There were no papers which fulfilled the inclusion criteria for this review, and therefore no data extraction was performed. Our search identified 172 potential studies for inclusion. However, following assessment none fulfilled the inclusion criteria for this review. Until relevant evidence is generated from randomised trials, the safety and efficacy of urinary alkalisers for the symptomatic treatment of uncomplicated UTI remains unknown.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
Unknown 83 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 14%
Student > Bachelor 12 14%
Student > Doctoral Student 10 12%
Researcher 7 8%
Other 6 7%
Other 23 27%
Unknown 14 17%
Readers by discipline Count As %
Medicine and Dentistry 34 40%
Nursing and Health Professions 12 14%
Pharmacology, Toxicology and Pharmaceutical Science 5 6%
Social Sciences 3 4%
Immunology and Microbiology 2 2%
Other 8 10%
Unknown 20 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 March 2020.
All research outputs
#4,765,752
of 17,359,532 outputs
Outputs from Cochrane database of systematic reviews
#7,212
of 11,660 outputs
Outputs of similar age
#78,097
of 269,731 outputs
Outputs of similar age from Cochrane database of systematic reviews
#120
of 183 outputs
Altmetric has tracked 17,359,532 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 11,660 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.0. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 269,731 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 183 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.